Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 67 articles:
HTML format

Single Articles

    January 2021
  1. KREIS I, Biegler R, Tjelmeland H, Mittner M, et al
    Overestimation of volatility in schizophrenia and autism? A comparative study using a probabilistic reasoning task.
    PLoS One. 2021;16:e0244975.
    PubMed     Abstract available

  2. REEVE S, Sheaves B, Freeman D
    Excessive sleepiness in patients with psychosis: An initial investigation.
    PLoS One. 2021;16:e0245301.
    PubMed     Abstract available

  3. PRESTA V, Paraboschi F, Marsella F, Lucarini V, et al
    Posture and gait in the early course of schizophrenia.
    PLoS One. 2021;16:e0245661.
    PubMed     Abstract available

  4. FORNS J, Layton JB, Bartsch J, Turner ME, et al
    Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
    PLoS One. 2021;16:e0246121.
    PubMed     Abstract available

  5. ASHER L, Birhane R, Teferra S, Milkias B, et al
    "Like a doctor, like a brother": Achieving competence amongst lay health workers delivering community-based rehabilitation for people with schizophrenia in Ethiopia.
    PLoS One. 2021;16:e0246158.
    PubMed     Abstract available

  6. CROFT J, Martin D, Madley-Dowd P, Strelchuk D, et al
    Childhood trauma and cognitive biases associated with psychosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0246948.
    PubMed     Abstract available

  7. MANTRI S, Klawson E, Albert S, Rapoport R, et al
    The experience of care partners of patients with Parkinson's disease psychosis.
    PLoS One. 2021;16:e0248968.
    PubMed     Abstract available

  8. JAWORSKI M, Panczyk M, Sliwczynski A, Brzozowska M, et al
    Schizophrenic patients with type 2 diabetes: An 8-year population-based observational study.
    PLoS One. 2021;16:e0248407.
    PubMed     Abstract available

  9. HINOJOSA-MARQUES L, Monsonet M, Kwapil TR, Barrantes-Vidal N, et al
    The impact of family environment on self-esteem and symptoms in early psychosis.
    PLoS One. 2021;16:e0249721.
    PubMed     Abstract available

  10. MAKI S, Nagai K, Ando S, Tamakoshi K, et al
    Structure and predictors of in-hospital nursing care leading to reduction in early readmission among patients with schizophrenia in Japan: A cross-sectional study.
    PLoS One. 2021;16:e0250771.
    PubMed     Abstract available

  11. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    PubMed     Abstract available

  12. HAYASHI N, Igarashi Y, Harima H
    Delusion progression process from the perspective of patients with psychoses: A descriptive study based on the primary delusion concept of Karl Jaspers.
    PLoS One. 2021;16:e0250766.
    PubMed     Abstract available

  13. ROSEN DL, Travers D
    Emergency department visits among patients transported by law enforcement officers.
    PLoS One. 2021;16:e0244679.
    PubMed     Abstract available

  14. KIM K, Duc NT, Choi M, Lee B, et al
    EEG microstate features for schizophrenia classification.
    PLoS One. 2021;16:e0251842.
    PubMed     Abstract available

  15. KRONBICHLER L, Stelzig-Scholer R, Lenger M, Weber S, et al
    Preserved intention understanding during moral judgments in schizophrenia.
    PLoS One. 2021;16:e0251180.
    PubMed     Abstract available

  16. LINCOLN SH, Johnson T, Kim S, Edenbaum E, et al
    Psychosis proneness, loneliness, and hallucinations in nonclinical individuals.
    PLoS One. 2021;16:e0251753.
    PubMed     Abstract available

  17. KOBORI A, Miyashita M, Miyano Y, Suzuki K, et al
    Advanced glycation end products and cognitive impairment in schizophrenia.
    PLoS One. 2021;16:e0251283.
    PubMed     Abstract available

  18. KURUKGY JL, Bourgin J, Benoit JP, Guessoum SB, et al
    Implementing organicity investigations in early psychosis: Spreading expertise.
    PLoS One. 2021;16:e0252610.
    PubMed     Abstract available

  19. NOROVSAMBUU O, Tsend-Ayush A, Lkhagvasuren N, Jav S, et al
    Main characteristics of dermatoglypics associated with schizophrenia and its clinical subtypes.
    PLoS One. 2021;16:e0252831.
    PubMed     Abstract available

  20. SCHILLING TM, Bossert M, Konig M, Wirtz G, et al
    Acute effects of a single dose of 2 mA of anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex on executive functions in patients with schizophrenia-A randomized controlled trial.
    PLoS One. 2021;16:e0254695.
    PubMed     Abstract available

  21. HUCKLE C, Lemmel F, Johnson S
    Experiences of friendships of young people with first-episode psychosis: A qualitative study.
    PLoS One. 2021;16:e0255469.
    PubMed     Abstract available

  22. SHOR O, Glik A, Yaniv-Rosenfeld A, Valevski A, et al
    EEG p-adic quantum potential accurately identifies depression, schizophrenia and cognitive decline.
    PLoS One. 2021;16:e0255529.
    PubMed     Abstract available

  23. JUNG YS, Kim YE, Go DS, Yoon SJ, et al
    The prevalence, incidence, and admission rate of diagnosed schizophrenia spectrum disorders in Korea, 2008-2017: A nationwide population-based study using claims big data analysis.
    PLoS One. 2021;16:e0256221.
    PubMed     Abstract available

  24. SHIMIZU J, Kuwata H, Kuwata K
    Differences in fractal patterns and characteristic periodicities between word salads and normal sentences: Interference of meaning and sound.
    PLoS One. 2021;16:e0247133.
    PubMed     Abstract available

  25. DUTRA-TAVARES AC, Manhaes AC, Semeao KA, Maia JG, et al
    Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model.
    PLoS One. 2021;16:e0257986.
    PubMed     Abstract available

  26. MARTIN J, Asjadi K, Hubbard L, Kendall K, et al
    Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression.
    PLoS One. 2021;16:e0248254.
    PubMed     Abstract available

  27. DOYEN S, Taylor H, Nicholas P, Crawford L, et al
    Hollow-tree super: A directional and scalable approach for feature importance in boosted tree models.
    PLoS One. 2021;16:e0258658.
    PubMed     Abstract available

    January 2020
  28. MONTAG C, Schoner J, Speck LG, Just S, et al
    Peripheral oxytocin is inversely correlated with cognitive, but not emotional empathy in schizophrenia.
    PLoS One. 2020;15:e0231257.
    PubMed     Abstract available

  29. Correction: Quality of life and its social determinants for patients with schizophrenia and family caregivers in Cambodia.
    PLoS One. 2020;15:e0232434.
    PubMed     Abstract available

  30. HEROLD CJ, Essig M, Schroder J
    Neurological soft signs (NSS) and brain morphology in patients with chronic schizophrenia and healthy controls.
    PLoS One. 2020;15:e0231669.
    PubMed     Abstract available

  31. ADDEPALLI A, Kalyani S, Singh M, Bandyopadhyay D, et al
    CalPen (Calculator of Penetrance), a web-based tool to estimate penetrance in complex genetic disorders.
    PLoS One. 2020;15:e0228156.
    PubMed     Abstract available

  32. GOUGH N, Brkan L, Subramaniam P, Chiuccariello L, et al
    Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
    PLoS One. 2020;15:e0223029.
    PubMed     Abstract available

  33. LEE DK, Lee H, Park K, Joh E, et al
    Common gray and white matter abnormalities in schizophrenia and bipolar disorder.
    PLoS One. 2020;15:e0232826.
    PubMed     Abstract available

  34. DEBAVEYE S, De Smedt D, Heirman B, Kavanagh S, et al
    Quantifying the handprint-Footprint balance into a single score: The example of pharmaceuticals.
    PLoS One. 2020;15:e0229235.
    PubMed     Abstract available

  35. LEE J, Green MF, Nuechterlein KH, Swerdlow NR, et al
    The effects of age and sex on cognitive impairment in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS) study.
    PLoS One. 2020;15:e0232855.
    PubMed     Abstract available

  36. DEHELEAN L, Romosan AM, Papava I, Bredicean CA, et al
    Prolactin response to antipsychotics: An inpatient study.
    PLoS One. 2020;15:e0228648.
    PubMed     Abstract available

  37. BARTH C, Lonning V, Gurholt TP, Andreassen OA, et al
    Exploring white matter microstructure and the impact of antipsychotics in adolescent-onset psychosis.
    PLoS One. 2020;15:e0233684.
    PubMed     Abstract available

  38. MORUP MF, Kymes SM, Oudin Astrom D
    A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States.
    PLoS One. 2020;15:e0234121.
    PubMed     Abstract available

  39. DONEGAN JJ, Boley AM, Glenn JP, Carless MA, et al
    Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia.
    PLoS One. 2020;15:e0232200.
    PubMed     Abstract available

  40. BAN KY, Osborn DPJ, Hameed Y, Pandey S, et al
    Personality disorder in an Early Intervention Psychosis cohort: Findings from the Social Epidemiology of Psychoses in East Anglia (SEPEA) study.
    PLoS One. 2020;15:e0234047.
    PubMed     Abstract available

  41. HINOJOSA-MARQUES L, Dominguez-Martinez T, Kwapil TR, Barrantes-Vidal N, et al
    Predictors of criticism and emotional over-involvement in relatives of early psychosis patients.
    PLoS One. 2020;15:e0234325.
    PubMed     Abstract available

  42. HUANG PS, Chen CL, Yeung KT, Hsu MY, et al
    Effects of different types of sensory signals on reaching performance in persons with chronic schizophrenia.
    PLoS One. 2020;15:e0234976.
    PubMed     Abstract available

  43. DREGAN A, McNeill A, Gaughran F, Jones PB, et al
    Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom.
    PLoS One. 2020;15:e0230674.
    PubMed     Abstract available

  44. JIN H, Tappenden P, Robinson S, Achilla E, et al
    Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia.
    PLoS One. 2020;15:e0234996.
    PubMed     Abstract available

  45. VIDAL-DOMENECH F, Riquelme G, Pinacho R, Rodriguez-Mias R, et al
    Calcium-binding proteins are altered in the cerebellum in schizophrenia.
    PLoS One. 2020;15:e0230400.
    PubMed     Abstract available

  46. SVENDSEN IH, Oie MG, Moller P, Nelson B, et al
    Basic self-disturbances are associated with Sense of Coherence in patients with psychotic disorders.
    PLoS One. 2020;15:e0230956.
    PubMed     Abstract available

  47. JO M, Kim HJ, Rim SJ, Lee MG, et al
    The cost-of-illness trend of schizophrenia in South Korea from 2006 to 2016.
    PLoS One. 2020;15:e0235736.
    PubMed     Abstract available

  48. DOR-NEDONSEL E, Menard ML, Fernandez A, Sakarovitch C, et al
    Early-Onset Schizophrenia in a paediatric population of French psychiatric and medico-social care centres: A cross sectional study.
    PLoS One. 2020;15:e0236241.
    PubMed     Abstract available

  49. LUCAS-MOLINA B, Perez-Albeniz A, Satorres E, Ortuno-Sierra J, et al
    Identifying extended psychosis phenotypes at school: Associations with socio-emotional adjustment, academic, and neurocognitive outcomes.
    PLoS One. 2020;15:e0237968.
    PubMed     Abstract available

  50. HENSON P, Pearson JF, Keshavan M, Torous J, et al
    Impact of dynamic greenspace exposure on symptomatology in individuals with schizophrenia.
    PLoS One. 2020;15:e0238498.
    PubMed     Abstract available

  51. MAHAR AL, Kurdyak P, Hanna TP, Coburn NG, et al
    The effect of a severe psychiatric illness on colorectal cancer treatment and survival: A population-based retrospective cohort study.
    PLoS One. 2020;15:e0235409.
    PubMed     Abstract available

  52. KITAGAWA K, So R, Nomura N, Mizuno Y, et al
    Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J).
    PLoS One. 2020;15:e0234864.
    PubMed     Abstract available

  53. LEE Y, Kim SK, Eom MR
    Usability of mental illness simulation involving scenarios with patients with schizophrenia via immersive virtual reality: A mixed methods study.
    PLoS One. 2020;15:e0238437.
    PubMed     Abstract available

  54. RAMCHANDRAN K, Fiedorowicz J, Chen Z, Bu Y, et al
    Patients on the psychosis spectrum employ an alternate brain network to engage in complex decision-making.
    PLoS One. 2020;15:e0238774.
    PubMed     Abstract available

  55. JOHANSSON KA, Okland JM, Skaftun EK, Bukhman G, et al
    Estimating Health Adjusted Age at Death (HAAD).
    PLoS One. 2020;15:e0235955.
    PubMed     Abstract available

  56. KUMSA A, Agenagnew L, Alemu B, Girma S, et al
    Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.
    PLoS One. 2020;15:e0235365.
    PubMed     Abstract available

  57. YAMAZAKI M, Honda S, Tamaki K, Irie M, et al
    Effects of (+)-bicuculline, a GABAa receptor antagonist, on auditory steady state response in free-moving rats.
    PLoS One. 2020;15:e0236363.
    PubMed     Abstract available

  58. ISHII J, Kodaka F, Miyata H, Yamadera W, et al
    Associations between parental bonding during childhood and functional recovery in patients with schizophrenia.
    PLoS One. 2020;15:e0240504.
    PubMed     Abstract available

  59. FUJII K, Yoshihara Y, Matsumoto Y, Tose K, et al
    Cognition and interpersonal coordination of patients with schizophrenia who have sports habits.
    PLoS One. 2020;15:e0241863.
    PubMed     Abstract available

  60. IZAUTE M, Thuaire F, Meot A, Rondepierre F, et al
    Metacognitive preserved generation strategy benefits for both younger and elderly participants with schizophrenia.
    PLoS One. 2020;15:e0241356.
    PubMed     Abstract available

  61. TORREY EF, Knable MB, Rush AJ, Simmons WW, et al
    Using the NIH Research, Condition and Disease Categorization Database for research advocacy: Schizophrenia research at NIMH as an example.
    PLoS One. 2020;15:e0241062.
    PubMed     Abstract available

  62. YAMAMOTO M, Bagarinao E, Kushima I, Takahashi T, et al
    Support vector machine-based classification of schizophrenia patients and healthy controls using structural magnetic resonance imaging from two independent sites.
    PLoS One. 2020;15:e0239615.
    PubMed     Abstract available

  63. ALAMEDA L, Levier A, Gholam-Rezaee M, Golay P, et al
    Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication.
    PLoS One. 2020;15:e0242569.
    PubMed     Abstract available

  64. LIM K, Lam M, Huang H, Liu J, et al
    Genetic liability in individuals at ultra-high risk of psychosis: A comparison study of 9 psychiatric traits.
    PLoS One. 2020;15:e0243104.
    PubMed     Abstract available

  65. BIRNBAUM ML, Wen H, Van Meter A, Ernala SK, et al
    Identifying emerging mental illness utilizing search engine activity: A feasibility study.
    PLoS One. 2020;15:e0240820.
    PubMed     Abstract available

  66. CHAFI YK, Amare T, Haile K, Damene W, et al
    Prevalence and correlates of job loss among schizophrenia outpatients at St. AmanuelMental Specialized Hospital, Addis Ababa, Ethiopia; cross sectional study.
    PLoS One. 2020;15:e0242352.
    PubMed     Abstract available

  67. IQBAL E, Govind R, Romero A, Dzahini O, et al
    The side effect profile of Clozapine in real world data of three large mental health hospitals.
    PLoS One. 2020;15:e0243437.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.